Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

Publisher Name :
Date: 31-Oct-2018
No. of pages: 302
Inquire Before Buying

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape.

Human papillomavirus (HPV) is the most common viral infection of the reproductive tract. Human papillomavirus (HPV) has been found to be associated with several types of cancer. Risk factors include smoking, weakened immune system, long-term oral contraceptive use and chronic inflammation. Human papillomavirus (HPV) associated cancer have no symptoms until it is quite advanced, very serious and hard to treat.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Human Papillomavirus (HPV) Associated Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Human Papillomavirus (HPV) Associated Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 22, 10, 41, 2 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 1, 11 and 2 molecules, respectively.

Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Human Papillomavirus (HPV) Associated Cancer (Oncology).

- The pipeline guide reviews pipeline therapeutics for Human Papillomavirus (HPV) Associated Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Human Papillomavirus (HPV) Associated Cancer (Oncology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Human Papillomavirus (HPV) Associated Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Human Papillomavirus (HPV) Associated Cancer (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Human Papillomavirus (HPV) Associated Cancer (Oncology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

Table of Contents
Table of Contents 2
Introduction 5
Human Papillomavirus (HPV) Associated Cancer - Overview 6
Human Papillomavirus (HPV) Associated Cancer - Therapeutics Development 7
Human Papillomavirus (HPV) Associated Cancer - Therapeutics Assessment 19
Human Papillomavirus (HPV) Associated Cancer - Companies Involved in Therapeutics Development 28
Human Papillomavirus (HPV) Associated Cancer - Drug Profiles 52
Human Papillomavirus (HPV) Associated Cancer - Dormant Projects 275
Human Papillomavirus (HPV) Associated Cancer - Discontinued Products 278
Human Papillomavirus (HPV) Associated Cancer - Product Development Milestones 279
Appendix 291

List of Tables
Number of Products under Development for Human Papillomavirus (HPV) Associated Cancer, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Abion Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Abivax SA, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Admedus Ltd, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Advaxis Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Antiva Biosciences Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Atara Biotherapeutics Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by BioNTech AG, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Cancer Research Technology Ltd, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Cue Biopharma Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Denceptor Therapeutics Ltd, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Etubics Corp, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by EyeGene Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Genexine Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Hookipa Biotech AG, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by iBio Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Immunomic Therapeutics Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by IMV Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Inovio Pharmaceuticals Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Iovance Biotherapeutics Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by ISA Pharmaceuticals BV, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Johnson & Johnson, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Juno Therapeutics Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Kite Pharma Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by MedImmune LLC, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Merck & Co Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Merck KGaA, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by NeoImmuneTech Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Onconova Therapeutics Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Oxford Vacmedix UK Ltd, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Pathovax LLC, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by PDS Biotechnology Corp, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Profectus BioSciences Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Rottapharm Biotech Srl, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Selecta Biosciences Inc, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Shanghai Zerun Biotechnology Co Ltd, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Shantha Biotechnics Pvt Ltd, H2 2018
Human Papillomavirus (HPV) Associated Cancer - Pipeline by Shuttle Pharmaceuticals Inc, H2 2018

List of Figures
Number of Products under Development for Human Papillomavirus (HPV) Associated Cancer, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Top 10 Routes of Administration, H2 2018
Number of Products by Stage and Top 10 Routes of Administration, H2 2018
Number of Products by Top 10 Molecule Types, H2 2018
Number of Products by Stage and Top 10 Molecule Types, H2 2018
  • Global Melanoma Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 02-Apr-2020        Price: US 3900 Onwards        Pages: 97
    This report focuses on the global Melanoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Melanoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - AstraZeneca - Amgen, Inc. - F. Hoffmann-La Roche Ltd. - Bristol-Myers Squibb Company - Novartis AG - Merck & ......
  • Small Molecule Targeted Cancer Therapy Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Mar-2020        Price: US 3000 Onwards        Pages: 147
    Small Molecule Targeted Cancer Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Small Molecule Targeted Cancer Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Small Molecule Targeted Cancer Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides a......
  • Global Circulating Tumor Cells Market Status and Future Forecast 2015-2025
    Published: 20-Mar-2020        Price: US 4500 Onwards        Pages: 166
    Summary This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others). The report forecast global Circulating Tumor Cells market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Circulating Tumor Cells industry and main mark......
  • Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 13-Mar-2020        Price: US 3000 Onwards        Pages: 135
    Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Endometrial Cancer Treatments industry with a focus on the Chinese market. The report provides key statistics on the market status of the Endometrial Cancer Treatments manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-......
  • Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2020-2026
    Published: 11-Mar-2020        Price: US 3900 Onwards        Pages: 96
    This report focuses on the global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioblastoma Multiforme Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - AbbVie, Inc - Activartis GmbH - Agenus Inc - Arog Pharmaceuticals, Inc - Bristol-Myers Squib......
  • Global Non-Hodgkin Lymphoma Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 10-Mar-2020        Price: US 3900 Onwards        Pages: 98
    This report focuses on the global Non-Hodgkin Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Hodgkin Lymphoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Bristol Myers Squibb - Celgene - Eli Lilly - F. Hoffman La-Roche - GlaxoSmithKline - ......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2020-2025
    Published: 10-Mar-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Circulating Tumor Cells market will register a 21.2% CAGR in terms of revenue, the global market size will reach $ 2273.7 million by 2025, from $ 1055 million in 2019. In particular, this report presents the global revenue market share of key companies in Circulating Tumor Cells business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Circulating Tumor Cells market ......
  • Cancer Gene Therapy Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Mar-2020        Price: US 3000 Onwards        Pages: 146
    Cancer Gene Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Gene Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Gene Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Cancer......
  • Cancer Therapeutics and Biotherapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Mar-2020        Price: US 3000 Onwards        Pages: 146
    Cancer Therapeutics and Biotherapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Therapeutics and Biotherapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Therapeutics and Biotherapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs